DOSE,

NAME AND FREQUENCY MECHANISM OF INDICATIONS CONTRAINDICATIONS ADVERSE NURSING

CLASSIFICATI ROUTE, ACTION EFFECTS RESPONSIBILIT
ON OF DRUG DURATION OF Y
ADMINISTRATI
ON
(Clonidine) 75mcg SL Clonidine stimul Clonidine is an  Anxiety  Monitor
PRN for BP > ates alpha- antihypertensive  depression . blood
Drug class: 130/90 adrenoceptors in drug that lowers  dry eye  blisteri pressure
centrally the brain stem. blood pressure and ng, and
acting alpha- This action heart rate by  a heart attack burning pulse
agonist results in reduced relaxing the arteries , rate
hypotensive sympathetic and increasing the  diminished crusting frequent
agents outflow from the blood supply to the blood flow , ly.
central nervous heart; it has other through dryness Dosage is
system and FDA-approved arteries of the , or usually
decreases in indications such as:  heart flaking adjusted
peripheral  Treatment of of the to the
resistance, renal  atrioventricular
attention skin. patient's
vascular block, a type
deficit  chest blood
resistance, heart of slow heart
hyperactivity pain or pressure
rate, and blood rhythm
disorder discomf and can
pressure. disorder
(ADHD) in ort. cause
children   sinus  confusi hypotensi
bradycardia on as to on,
 Management bradycar
time,
of tics  a disorder of dia, and
place,
commonly the blood sedation.
or
found with vessels of the person.
Tourette brain  Monitor
syndrome  decreas
ed urine patient
 Raynaud's response
 Adjunct phenomenon, a output.
  dilated to
therapy for condition therapy
neck
severing where blood through
veins.
cancer- vessels blood
 fast,
related pain constrict too pressure
poundi
much with monitori
ng, or
coldness or ng.
irregula
stress
r
 recent heartbe
operation at or  Monitor
pulse. for
 chronic kidney gen adverse
disease stage 5 eral feeling effects
(failure) of (e.g. skin
discomfort reactions,
or illness. cough,
headache
, etc.)

 Evaluate
patient
understan
ding on
drug
therapy
by asking
patient to
name the
drug, its
indicatio
n, and
adverse
effects to
 watch
for.

 Monitor
patient
complian
ce to
drug
therapy.